Trade Biomerieux - BIM CFD
Add to favourite- Summary
- Historical Data
Spread | 0.50 | ||||||||
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.02141% | ||||||||
Short position overnight fee
Short position overnight funding adjustment
Go to platform | -0.000812% | ||||||||
Overnight fee time | 21:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | EUR | ||||||||
Margin | 5.00% | ||||||||
Stock exchange | France | ||||||||
Commission on trade | 0% |
Prev. Close | 96.3 |
Open | 96.4 |
1-Year Change | 1.15% |
Day's Range | 96.4 - 98.5 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Jul 25, 2024 | 96.00 | 0.90 | 0.95% | 95.10 | 96.35 | 94.35 |
Jul 24, 2024 | 94.80 | 2.00 | 2.16% | 92.80 | 95.10 | 92.75 |
Jul 23, 2024 | 93.70 | 0.30 | 0.32% | 93.40 | 94.65 | 93.00 |
Jul 22, 2024 | 93.75 | 1.40 | 1.52% | 92.35 | 94.45 | 91.90 |
Jul 19, 2024 | 92.55 | -1.35 | -1.44% | 93.90 | 93.90 | 92.40 |
Jul 18, 2024 | 94.35 | 0.55 | 0.59% | 93.80 | 94.85 | 93.45 |
Jul 17, 2024 | 93.70 | 0.50 | 0.54% | 93.20 | 93.90 | 92.65 |
Jul 16, 2024 | 93.30 | -1.20 | -1.27% | 94.50 | 94.50 | 92.60 |
Jul 15, 2024 | 94.85 | -0.70 | -0.73% | 95.55 | 96.30 | 94.50 |
Jul 12, 2024 | 95.95 | 1.90 | 2.02% | 94.05 | 96.05 | 93.80 |
Jul 11, 2024 | 94.45 | 2.60 | 2.83% | 91.85 | 94.75 | 91.60 |
Jul 10, 2024 | 91.45 | 0.95 | 1.05% | 90.50 | 91.85 | 90.50 |
Jul 9, 2024 | 91.10 | 0.00 | 0.00% | 91.10 | 92.70 | 90.85 |
Jul 8, 2024 | 91.85 | -1.70 | -1.82% | 93.55 | 94.05 | 91.70 |
Jul 5, 2024 | 93.55 | 0.60 | 0.65% | 92.95 | 93.85 | 92.85 |
Jul 4, 2024 | 93.20 | 2.80 | 3.10% | 90.40 | 93.35 | 90.05 |
Jul 3, 2024 | 89.90 | 0.35 | 0.39% | 89.55 | 90.70 | 89.00 |
Jul 2, 2024 | 89.65 | 0.70 | 0.79% | 88.95 | 90.10 | 87.85 |
Jul 1, 2024 | 89.85 | 0.25 | 0.28% | 89.60 | 90.45 | 88.15 |
Jun 28, 2024 | 88.90 | -1.15 | -1.28% | 90.05 | 90.35 | 88.70 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Biomerieux Company profile
About BioMerieux SA
Biomerieux SA is a France-based company that specializes in the field of in-vitro diagnostics for medical and industrial applications. The Company designs, develops, manufactures and sells systems used in clinical applications, such as for the diagnosis of tuberculosis, respiratory infections, among others and industrial applications, such as for the analysis of industrial or environmental samples. The Company also provides its customers with related services for the installation and maintenance of instruments, and training for product users. BioMerieux SA operates through its numerous subsidiaries in various countires, including bioMerieux Deutschland GmbH, bioMerieux Austria GmbH, Advencis, bioMerieux Benelux SA/NV, as well as BioFire Diagnostics Inc., chromID CARBA SMART and new bi-plate Petri dish.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, BioMerieux SA revenues increased 8% to EUR3.38B. Net income applicable to common stockholders increased 49% to EUR601.1M. Revenues reflect Microbiology segment increase of 12% to EUR1.06B, Molecular Biology segment increase of 5% to EUR1.27B, Europe & Middle East & Africa (EMEA) (Region) segment increase of 10% to EUR1.12B, America segment increase of 5% to EUR1.67B.
Equity composition
9/2017, 3-for-1 stock split (Factor: 3).
Industry: | Laboratory Diagnostic & Testing Substances |
376, chemin de l'Orme
CRAPONNE
AUVERGNE-RHONE-ALPES 69280
FR
News
![](https://img.capital.com/imgs/articles/192x130x1/Risk-Management-in-Trading.png)
How to manage risk when trading
Learn what risk management is and find out how understanding about it could help you identify potential risks in your investment portfolio. Find out more.
06:57, 22 July 2024![](https://img.capital.com/imgs/articles/192x130x1/ECB_0.png)
ECB preview: lack of new data sees markets expecting a hold
Markets expect the ECB to keep rates unchanged in July but expectations for a September cut rise
13:13, 18 July 2024![](https://img.capital.com/imgs/articles/192x130x1/risk_2_1_optimized_450_1.png)
What is an IPO and how does it work?
Learn about what an IPO is, why they are important, and how they work.
07:19, 10 July 2024![](https://img.capital.com/imgs/articles/192x130x1/Stock-1-_1.png)
What are the biggest stock exchanges worldwide?
Discover the largest stock exchanges in the world by market capitalisation, including the Nasdaq Stock Market, the New York Stock Exchange and the London Stock Exchange.
12:44, 9 July 2024![](https://img.capital.com/imgs/articles/192x130x1/ETF-1-_0.png)
Top ETFs
ETFs, or exchange-traded funds, offer traders a versatile gateway into the financial markets.
16:23, 8 July 2024![Lloyds share price forecast: An attractive dividend stock? Lloyds share price forecast: An attractive dividend stock?](https://img.capital.com/imgs/articles/192x130x1/shutterstock_536730610_0.jpg)
Lloyds forecast: will Lloyds share price return to £1? Third party data forecast
What’s next for Lloyds amid higher inflation and the start of a potential recessionary cycle in the UK?
14:00, 8 July 2024![](https://img.capital.com/imgs/articles/192x130x1/RBNZ.png)
RBNZ Preview: OCR expected to remain unchanged as central bank focuses on inflation
The Reserve Bank of New Zealand meets on Wednesday, July 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
13:25, 8 July 2024People also watch
Still looking for a broker you can trust?
Join the 630,000+ traders worldwide that chose to trade with Capital.com